RecruitingNot ApplicableNCT05714826

Comprehensive Optimization At-time of Radical Cystectomy Intervention

Comprehensive Optimization At-time of Radical Cystectomy Intervention Through Peri-operative Patient Care Program


Sponsor

University of Texas Southwestern Medical Center

Enrollment

194 participants

Start Date

Apr 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The proposed study is aimed at a comprehensive optimization at-time of radical cystectomy (COARC) intervention that focuses on patient optimization throughout the perioperative continuum, from the pre-operative setting to the post-operative period, among patients undergoing radical cystectomy for bladder cancer. This multi-modal strategy will focus on three phases of care around surgery: the pre-operative, peri-operative, and post-operative phases. The intervention group will focus on multiple areas of patient optimization including remote patient monitoring for the earlier identification of potential complications. The overall study mission is to decrease complication rates after radical cystectomy using this comprehensive approach.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adults equal to or more than 18 years old
  • Diagnosis of bladder cancer with plan to undergo radical cystectomy
  • Agrees to participate in study procedures

Exclusion Criteria2

  • Patients undergoing cystectomy for diagnosis other than bladder cancer
  • Do not provide informed consent

Interventions

OTHERPreop Intervention and Monitored Recovery

Perioperative Optimization of Senior Health (POSH) Program; patient monitoring by device orientation, initial intake, education; ERAS protocol, inpatient geriatric co-management; and remote monitoring with Acticare device; post-op continuity of care

OTHERUsual Care

ERAS, Usual referral and recovery care, and Standard follow-up protocol


Locations(1)

University of Texas Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05714826


Related Trials